申请人:Eli Lilly and Company
公开号:US06133262A1
公开(公告)日:2000-10-17
This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of the compounds of formula I as thrombin inhibitors.
该申请涉及到式I的新化合物(及其药用可接受的盐),如本文所定义,用于制备它们的过程和中间体,包含式I新化合物的药物配方,以及将式I化合物用作凝血酶抑制剂的用途。